ARCHIVES

Phase III Avastin Trial Fails Primary Endpoints

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

Melanoma Vaccine Near Phase 3, Other Studies Discussed At ACS Seminar

April 13, 1990

Wyngaarden Helps Make Case For Facilities Funding, Reveals Plan For New NIH Building

April 15, 1988

Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease

August 30, 2013

Komen Foundation Grant Recipients Are Listed

August 13, 1993

Surgeon General Issues Call To Reduce Skin Cancer Rates

August 1, 2014

Survival For ALL Increased To 94 Percent In Recent Years

December 31, 2010